Exercise prescription for the prevention and treatment of cardiovascular diseases: Part I

Journal of Cardiovascular Medicine

Volumn 9, Issue 5, 2008, Pages 529-544

  Giada, Franco ^a,s   Biffi, Alessandro ^b   Agostoni, Piergiuseppe ^c   Anedda, Alberto ^d   Belardinelli, Romualdo ^e   Carlon, Roberto ^f   Carù, Bruno ^g   D'Andrea, Luigi ^h   Delise, Pietro ⁱ   De Francesco, Antonino ^j   Fattirolli, Francesco ^k   Guglielmi, Riccardo ^l   Guiducci, Umberto ^m   Pelliccia, Antonio ^b   Penco, Maria ⁿ   Perticone, Francesco ^o   Thiene, Gaetano ^p   Vona, Margherita ^q   Zeppilli, Paolo ^r  

^a Umberto I Hospital   (Italy)

^b Italian National Olympic Committee   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Service of Sports Medicine   (Italy)

^e Ospedale Monospecialistico Cardiologico GM Lancisi   (Italy)

^f Cittadella General Hospital   (Italy)

^g CNR   (Italy)

^h UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁱ Civic Hospital   (Italy)

^j SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^k CAREGGI UNIVERSITY HOSPITAL   (Italy)

^l POLICLINICO   (Italy)

^m Cardiovascular Department   (Italy)

ⁿ UNIVERSITY OF L'AQUILA   (Italy)

^o UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^p UNIVERSITY OF PADOVA   (Italy)

^q Ospedale Beauregard   (Italy)

^r CATHOLIC UNIVERSITY   (Italy)

^s Umberto I Hospital   (Italy)

more..

Author keywords

Cardiovascular diseases; Exercise prescription; Physical activity

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; FIBRINOLYTIC AGENT; HYPOCHOLESTEROLEMIC AGENT; INSULIN;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; DYSLIPIDEMIA; ENDOTHELIUM; EXERCISE; HEART INFARCTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; LEGAL ASPECT; LIFESTYLE MODIFICATION; MEDICAL DOCUMENTATION; MEDICAL SOCIETY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT ASSESSMENT; PHYSICAL ACTIVITY; POPULATION; PRESCRIPTION; PRIMARY PREVENTION; REVIEW; RISK ASSESSMENT; SCREENING; SECONDARY PREVENTION; SPORT; STANDARD; STATIC EXERCISE; SUDDEN DEATH; TRAINING; TRANSLUMINAL CORONARY ANGIOPLASTY;

CARDIOVASCULAR DISEASES; EXERCISE THERAPY; HUMANS; RISK FACTORS;

EID: 42049102594     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3282f7ca77     Document Type: Review

References (58)

1. World Health Organization. The World Health Report 2002: reducing risk, promoting healthy life.
2. Booth FW, Gordon SE, Carlson CJ, Hamilton MT. Waging war on modern chronic diseases: primary prevention through exercise biology. J Appl Physiol 2000; 88:774-787.
3. Blair SN, Kohl HW 3rd, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA 1995; 273:1093-1098.
4. Paffenbarger RS Jr, Kampert JB, Lee IM, Hyde RT, Leung RW, Wing AL. Changes in physical activity and other life way patterns influencing longevity. Med Sci Sports Exerc 1994; 26:857-865.
5. Erikssen G, Liestol K, Bjornholt J, Thaulow E, Sandvik L, Erikssen J. Changes in physical fitness and changes in mortality. Lancet 1998; 352:759-762.
6. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346:793-801.
7. Manson JE, Greenland P, La Croix AZ, Stefanick ML, Mouton CP, Oberman A, et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 2002; 347:716-725.
8. Sesso HD, Paffenbarger RS, Lee IM. Physical activity and coronary heart disease in men: the Harvard Alumni Health Study. Circulation 2000; 102:975-980.
9. Franco OH, de Laet C, Peeters A, Jonker J, Mackenbach J, Nusselder W. Effects of physical activity on life expectancy with cardiovascular disease. Arch Intern Med 2005; 165:2355-2360.
10. O'Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger RS Jr, et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989; 80:234-244.
11. Oldridge NB, Guyatt GH, Fischer ME, Rimm AA. Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA 1988; 260:945-950.
12. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, et al. Exercise-based rehabilitation for patients with coronary artery disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004; 116:682-692.
13. Jones TF, Eaton CB. Cost-benefit analysis of walking to prevent coronary heart disease. Arch Fam Med 1994; 3:703-710.
14. Sevick MA, Dunn AL, Morrow MS, Marcus BH, Chen GJ, Blair SN. Cost-effectiveness of lifestyle and structured exercise interventions in sedentary adults. Results of Project ACTIVE. Am J Prev Med 2000; 19:1-8.
15. Hatziandreu EI, Koplan JP, Weinstein MC, Caspersen CJ, Warner KE. A cost-effectiveness analysis of exercise as a health promotion activity. Am J Public Health 1988; 78:1417-1421.
16. Oldridge N, Furlong W, Feeny D. Economic evaluation of cardiac rehabilitation soon after myocardial infarction. Am J Cardiol 1993; 72:1093-1098.
17. Levin LA, Perk J, Hedback B. Cardiac rehabilitation: a cost analysis. J Intern Med 1991; 230:427-434.
18. Lowensteyn I, Coupal L, Zowall H, Grover SA. The cost-effectiveness of exercise training for the primary and secondary prevention of cardiovascular disease. J Cardiopulm Rehab 2000; 20:147-153.
19. Ades PA, Pashkow FJ, James R. Cost-effectiveness of cardiac rehabilitation after myocardial infarction. J Cardiopulm Rehab 1997; 17:222-231.
20. Bonetti A. Attività fisica, metabolismo lipidico e rischio cardiovascolare. Sport Card 2001; II:159-168.
21. Halbert JA, Silagy CA, Finucane P, Withers RT, Hamdolf PA. Exercise training and blood lipids in hyperlipidemic and normolipidemic adults: a meta-analysis of randomized, controlled trials. Eur J Clin 1999; 53:514-522.
22. Tanasescu M, Leitzmann MF, Rimm EB, Hu FB. Physical activity in relation to cardiovascular disease and total mortality among men with type II diabetes. Circulation 2003; 107:2435-2439.
23. Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type II diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 2001; 286:1218-1227.
24. Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 2003; 108:1541-1545.
25. Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002; 105:546-5494.
26. Wang J, Wolin MS, Hintze TH. Chronic exercise enhances endothelium-mediated dilation of epicardial coronary arteries in conscious dogs. Circ Res 1993; 73:829-838.
27. Vona M, Rossi A, Capodaglio P. Impact of physical training and detraining on endothelium-dependent vasodilation in patients with recent acute myocardial infarction. Am Heart J 2004; 147:1039-1046.
28. Hambrecht R, Fiehn E, Weigl C. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 1998; 98:2709-2715.
29. Agostoni PG, Bianchi M, Moraschi A, Palermo P, Cattadori G, La Gioia R, et al. Work rate affects cardiopulmonary exercise test results in heart failure. Eur J Heart Fail 2005; 7:498-504.
30. Weber KT, Janicki JS. Cardiopulmonary exercise testing for evaluation of chronic cardiac failure. Am J Cardiol 1985; 55:22A-31A.
31. Agostoni PG, Cattadori G, Apostolo A, Contini M, Palermo P, Marenzi GC. Non invasive measurement of cardiac output during exercise by inert gas rebreathing technique: a new tool for heart failure evaluation. J Am Coll Cardiol 2005; 46:1779-1781.
32. Agostoni PG, Pellegrino R, Conca C, Rodarte J, Brusisco V. Exercise hyperpnea in chronic heart failure: relation to lung stiffness and exercise flow limitation. J Appl Physiol 2002; 92:1409-1416.
33. Delise P, Guiducci U, Zeppilli P, D'Andrea L, Proto C, Bellini R, et al. Cardiological guidelines for competitive sports eligibility. Ital Heart J 2005; 6:661-702.
34. Maron BJ, Zipes D. 36th Bethesda conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2005; 45:1318-1321.
35. Thompson PD. The cardiovascular complications of vigorous physical activity. Arch Intern Med 1996; 156:2297-2302.
36. Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE. Triggering of acute myocardial infarction by heavy exertion. N Engl J Med 1993; 329:1677-1683.
37. Thompson PD, Funk EJ, Careton RA, Sturner WQ. Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA 1982; 247:2535-2538.
38. Van Camp SP, Bloor CM, Mueller FO, Cantu RC, Olson HG. Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc 1995; 27:199-204.
39. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003; 42:1959-1963.
40. Maron BJ. Sudden death in young athletes. N Engl J Med 2003; 349:1064-1075.
41. Maron BJ, Thompson PD, Puffer JC, McGrew CA, Strong WB, Douglas PS, et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from Sudden Death Committee (Clinical Cardiology) and Congenital Cardiac Defects Committee (Cardiovascular disease in the Young), American Heart Association. Circulation 1996; 94:850-856.
42. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006; 296:1593-1601.
43. Maron BJ, Araujo CGS, Thompson PD, Fletcher GF, Bayes de Luna A, Fleg JL, et al. Recommendation for preparticipation screening and the assessment of cardiovascular disease in master athletes. An advisory for healthcare professionals from the Working Groups of the World Heart Federation, the International Federation of Sports Medicine, and American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation 2001; 103:327-334.
44. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, et al. Exercise standards for testing and training. A statement for healthcare professionals from the American Heart Association. Circulation 2001; 104:1694-1740.
45. Corrado D, Pelliccia A, Bjornstad HH, Vanhees L, Biffi A, Borjesson M, et al. Cardiovascular preparticipation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus statement of the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005; 26:516-524.
46. D'Andrea L. La prescrizione sport-terapeutica per la qualità di vita del cardiopatico ischemico. Int J Sports Cardiol 1993; 2:201-204.
47. Balady GJ, Chaitman B, Driscoll D, Foster C, Froelicher E, Gordon N, et al. An AHA/ACSM scientific statement. Recommendations for cardiovascular screening, staffing and emergency policies at health/fitness facilities. Circulation 1998; 97:2283-2293.
48. McInnis KJ, Hayakawa S, Balady GJ. Cardiovascular screening and emergency procedures at health clubs and fitness centres. Am J Cardiol 1997; 80:380-383.
49. American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness and flexibility in healthy adults. Med Sci Sports Exerc 1998; 30:975-991.
50. Pollock ML, Franklin BA, Balady GJ, Chaitman BL, Fleg JL, Fletcher B, et al. Resistance exercise in individuals with and without cardiovascular disease. Benefits, rationale, safety and prescription. An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation 2000; 101:828-833.
51. Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stewart KJ, et al. Cardiac rehabilitation and secondary prevention of coronary heart disease. An American Heart Association statement from the Council on Clinical Cardiology and the Council on Nutrition, Physical Activity, and Metabolism, in collaboration with the America Association of Cardiovascular and Pulmonary Rehabilitation. Circulation 2005; 111:369-376.
52. Thompson PD. Exercise precription and proscription for patients with coronary artery disease. Circulation 2005; 112:2354-2363.
53. Marchionni N, Fattirolli F, Fumagalli S. Improved exercise tolerance and quality of life with cardiac rehabilitation of older patients after myocardial infarction: results of a randomized, controlled trial. Circulation 2003; 107:2201-2206.
54. Pasquali SK, Alexander KP, Coombs LP, Lytle BL, Peterson ED. Effect of cardiac rehabilitation on functional outcomes after coronary revascularization. Am Heart J 2003; 145:445-451.
55. Belardinelli R, Paolini I, Cianci G, Piva R, Georgiou D, Purcaro A. Exercise training intervention after coronary angioplasty: the ETICA trial. J Am Coll Cardiol 2001; 37:1891-1900.
56. Hambrecht R, Walter C, Mobius-Winkler S, Gielen S, Linke A, Conradi K, et al. Percutaneous coronary angioplasty compared with exercise in patients with stable coronary artery disease. Circulation 2004; 109:1371-1378.
57. Wannamethee SG, Shaper AG, Walker M. Physical activity and mortality in older men with diagnosed coronary heart disease. Circulation 2000; 102:1358-1363.
58. Kavanagh T, Mertens DJ, Hamm LF. Prediction of long-term prognosis in 12169 men referred for cardiac rehabilitation. Circulation 2002; 106:666-671.